Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

IL-1 blockers CK-119 and CK-122 inhibit corneal fibroblast-like cell proliferation

Aug. 28, 1998

Future antiglaucoma drug candidates added to the pipeline at Alcon

Aug. 24, 1998

PGF2alpha derivative from Allergan reduces ocular hypertension in monkeys

Aug. 20, 1998

Sugen reaches milestone in collaborative agreement with Allergan

Aug. 10, 1998

First SELEX compound from NeXstar heads for clinical trials in ARMD

July 27, 1998

Troponin I inhibits retinal angiogenesis in animal studies

July 27, 1998

Herpes simplex virus vaccine reduces HSV-1 corneal disease

July 24, 1998

BioLon receives FDA approval

July 23, 1998

FDA grants fast track status to Miravant's Purlytin

July 10, 1998

Allergan signs collaborative agreement with Santen for brimonidine

July 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...